£43k
vs Feb 2025ActiveSC688453Private limited companyEdinburgh
PROZYMI BIOLABS LTD
Significant control: Ioannis Stasinopoulos (25–50%), Andreas Andreou (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Prozymi Biolabs Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PROZYMI BIOLABS LTD is an active private limited company (company number SC688453) incorporated on 8 February 2021, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2026, showing net assets of £43k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 8934% on the prior period (−£492). Across the last 3 periods on record the net-asset trend is rising.
Peer position · net assets
By net assets it sits in the upper half of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
02
Ownership and control
- Dr Ioannis Stasinopoulos
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr. Andreas Andreou
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 February 20215 yrs ago
- Next accounts due
- 28 November 2027in 401 days
- Confirmation statement due
- 22 February 2027in 122 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
3
No changevs Feb 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2026 | £43k | — | — | £18k | — | — | 3 |
| 28 February 2025 | −£492 | — | — | £20k | — | — | 3 |
| 29 February 2024 | −£13k | — | — | £26k | — | — | 3 |
Current ratio4.81Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £43,464 at 28 February 2026
- Net assets up 10% or more on the prior period+8934.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.81
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 8 February 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 401 days
- Confirmation statement duein 122 days
- Accounts period endNet assets £43k · micro accounts
- Accounts period endNet liabilities £492 · micro accounts
- Accounts period endNet liabilities £13k · micro accounts
- Incorporated
08
Similar companies in Edinburgh
- LINDVILLE BIO LTDEdinburgh · inc. Mar 2021
- PROTHEA TECHNOLOGIES LIMITEDEdinburgh · inc. Jun 2021
- E.V.A BIOSYSTEMS LIMITEDEdinburgh · inc. Aug 2021
- MERCEL LTDEdinburgh · inc. Oct 2021
- TARGOPEP LIMITEDEdinburgh · inc. Nov 2021
- LARIO THERAPEUTICS LIMITEDEdinburgh · inc. Nov 2021
All companies incorporated on 8 February 2021 · in Feb 2021.
09
Reminders for PROZYMI BIOLABS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.